Dr Vibeke Catts is the Study Coordinator for the Older Australian Twins Study (OATS) at the Centre for Health Brain Ageing (CHeBA), UNSW Sydney. OATS is a longitudinal, multi-centre study that investigates healthy brain ageing in older twins (65+ years) using measures of daily living, memory, genetics, blood biochemistry and imaging. 

Prior to joining the team at CHeBA, Dr Catts held a post-doctoral appointment in the Schizophrenia Research Laboratory at Neuroscience Research Australia, where she applied her skills as a molecular biologist to explore molecular and cellular pathology in blood and brain from individuals with schizophrenia. Dr Catts has a long-standing collaboration A/Prof Lutze-Mann in School of Biotechnology and Biomolecular Sciences, UNSW Sydney investigating antipsychotic drugs as a potential treatment for glioblastoma. This work is funded by Cure Cancer Australia.